Dr. Xiaoyan Zhang obtained her Ph.D. degree from department of Pharmacology and Toxicology in University of Louisville in 2008. Prior to joining the Graduate Program in Louisville, She obtained her M.S. degree from Epidemiology department in Fudan University. Her past research was focused on cancer association with drug metabolizing enzyme N-acetyltransferase and she had eight peer reviewed published papers. Her current work in the Center for Protein Therapeutics is to investigate the role of Fc-gamma receptors in the elimination of monoclonal antibodies.